All Type of News
Revised bill of pharmaceutical affairs law to be presented to National Assembly.
The MOHW plans to present the revised bill of the pharmaceutical affairs law in the middle of this month covering several key issues related to the forthcoming implementation of the medical and pharmacy separation pro...
Revised bill of pharmaceutical affairs law passed through the cabinet council.
The revised bill of pharmaceutical affairs law mainly covering the medical and pharmacy separation plan passed through the State Council meeting on Nov. 9, which will be, then, presented to the National Assembly soone...
FDA permits transfer of product and business licence
The KFDA has granted a transfer of the product and business licence for the first time, which seems to provide a strong motivation to the domestic drug industry for restructuring and redesigning of company management...
Working rules of Pharmaceutical Affairs Law to effect from this month
For the purpose of alleviating the drug manufacture and import controls, strengthening the industrial competitiveness and ameliorating a part of unsatisfactory points found in process of current practices, the MOHW am...
Sales strategy of drug industry on cross road.
The MOHW already announced for the insurance drug price reduction to take effect from Nov. 15. However, the drug industry faced in a dilemma whether they should place their sales expansion campaign with the old prices...
MOHW presented 13 different bills of laws to National Assembly.
13 bills including the revised pharmaceutical affairs law are presented to the National Assembly for passing during the ordinary session and additional 5 bills will be presented to the next ordinary session.
The 11...
Uniformity in number of patients for clinical test to be modified.
The new drug re-evaluation system implemented from 1995 has to be reasonably readjusted in its provisional requirement of tested patient numbers that should be varied by different preparations in consideration with ea...
10 leading drug makers unlikely to achieve this year sales target.
The sales of 10 leading pharmaceutical firms during the past 3 quarters this year showed 8.5% growth on average compared to the previous year period, which was 72 % achievement from their yearly target of 12....
False report of actual purchasing prices to be prosecuted.
Any medical institute or drug company may be penalized by either a criminal charge or a redemption for the balance of drug purchasing margins if the actual purchasing prices are reported false.
With regard to the i...
Identified description on unit dosed pack to postpone 3 to 5 more years
The KFDA plans to give a 3 to 5 year probation period for an individual unit dosed drug to mark an identification and to be obligated to pack, which reflected to the revised bill of the pharmaceutical affairs law now ...
